Mode
Text Size
Log in / Sign up

Cervical cytology abnormalities and HPV prevalence in Turkish women over 12 years

Cervical cytology abnormalities and HPV prevalence in Turkish women over 12 years
Photo by Navy Medicine / Unsplash
Key Takeaway
Consider that younger women (18–20 years) had the highest cervical cytology abnormality rate (12.78%) in this single-center retrospective study.

This retrospective cohort study analyzed 83,148 cervical smear records (76,232 evaluable) from women aged ≥21 years at a tertiary care center in Istanbul, Turkey, over a 12-year period (January 2014 to December 2025). The study aimed to describe the distribution and temporal trends of cervical cytological abnormalities, HPV prevalence and genotype distribution, and cytology-histopathology concordance.

The overall epithelial cell abnormality rate was 7.93%. The most common abnormality was atypical squamous cells of undetermined significance (5.83%), followed by low-grade squamous intraepithelial lesions (1.77%). Notably, the epithelial cell abnormality rate was highest in the 18–20 age group at 12.78%, and there was a significant inverse correlation between abnormality rate and age (r = −0.955, p < 0.05).

HPV testing was performed on a subset of the study population based on clinical indications and kit availability, which limits the generalizability of HPV prevalence data. Safety and tolerability were not reported. The study is retrospective and from a single tertiary care center, which may limit its external validity.

For clinicians, these findings highlight that younger women (18–20 years) have a higher rate of cervical cytological abnormalities, which may inform screening strategies. However, due to the study's limitations, these results should be interpreted cautiously and not directly extrapolated to other populations.

Study Details

Study typeCohort
EvidenceLevel 3
PublishedApr 2026
View Original Abstract ↓
IntroductionCervical cancer screening through cytology and human papillomavirus (HPV) testing is essential for early detection of precancerous lesions, yet long-term institutional data integrating cytological trends, HPV genotype epidemiology, and diagnostic performance from Turkey remain limited. This study aimed to analyze the distribution and temporal trends of cervical cytological abnormalities, HPV prevalence and genotype distribution, and cytology-histopathology concordance over a 12-year period at a tertiary care center in Istanbul.MethodsA retrospective analysis of all cervical smear samples collected between January 2014 and December 2025 was conducted. Cytology results were classified according to the Bethesda 2014 system. HPV testing, which was performed on a subset of the study population based on clinical indications and kit availability, included mRNA-based assay (Aptima, 2020–2021, n = 4,648) and DNA genotyping (2024–2025, n = 4,308). Cytology-histopathology correlation was assessed for cases with biopsy within 180 days.ResultsAmong 83,148 cervical smear records, 76,232 evaluable results from women aged ≥21 years were included. The overall epithelial cell abnormality rate was 7.93%, with atypical squamous cells of undetermined significance (5.83%) and low-grade squamous intraepithelial lesions (1.77%) being the most common findings. Epithelial cell abnormality rates varied significantly across age groups, with the highest rate in the 18–20 age group (12.78%) and a significant inverse correlation with increasing age (r = −0.955, p 
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.